{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:02:36Z","timestamp":1781715756026,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clnesp.2025.11.010","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:47:10Z","timestamp":1762962430000},"page":"622-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gender\u2013specific associations between metabolic dysfunction-associated fatty liver disease with atherosclerosis, inflammation, and eating habits"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0820-2611","authenticated-orcid":false,"given":"Gaston A.","family":"Rodriguez-Granillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana","family":"Poggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra B.","family":"Rubilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Y.","family":"Garron-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Solari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"La Greca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Luzzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina V.","family":"Arnone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ingino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Miriuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clnesp.2025.11.010_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.11.010_bib2","first-page":"261","article-title":"The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease","volume":"19","author":"Eslam","year":"2025","journal-title":"Hepatol lnt"},{"key":"10.1016\/j.clnesp.2025.11.010_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2017.08.006","article-title":"Nonalcoholic fatty liver disease associated with metabolic syndrome: influence of liver fibrosis stages on characteristics of very low-density lipoproteins","volume":"473","author":"Lucero","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.010_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0029-1222606","article-title":"Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome","volume":"35","author":"Targher","year":"2009","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.010_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12916-023-03028-w","article-title":"Plant-based diets, genetic predisposition and risk of non-alcoholic fatty liver disease","volume":"21","author":"Lv","year":"2023","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.010_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/liv.13435","article-title":"The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms","volume":"37","author":"Zelber-Sagi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.clnesp.2025.11.010_bib7","doi-asserted-by":"crossref","first-page":"117469","DOI":"10.1016\/j.ecoenv.2024.117469","article-title":"Air pollution exposure and prevalence of non-alcoholic fatty liver disease and related cirrhosis: a systematic review and meta-analysis","volume":"289","author":"He","year":"2025","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.010_bib8","first-page":"56","article-title":"Fatty liver disease and Gut Microbiota: a comprehensive update","volume":"7","author":"Campo","year":"2019","journal-title":"J Clin Tanslat Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.010_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","article-title":"Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma","volume":"74","author":"Ha","year":"2024","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.010_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cgh.2021.05.056","article-title":"A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores","volume":"20","author":"De Vincentis","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clnesp.2025.11.010_bib11","doi-asserted-by":"crossref","first-page":"101111","DOI":"10.1016\/j.aohep.2023.101111","article-title":"Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina","volume":"28","author":"Villamil","year":"2023","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.010_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1665-2681(19)31584-4","article-title":"Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile","volume":"10","author":"Cotrim","year":"2011","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.010_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcct.2018.03.008","article-title":"CAC-DRS: coronary artery calcium data and reporting system. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT)","volume":"12","author":"Hecht","year":"2018","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.010_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.acra.2012.02.022","article-title":"Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis","volume":"19","author":"Zeb","year":"2012","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.010_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clnesp.2025.11.010_bib16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/RCT.0b013e318159a49e","article-title":"Comparison of methods to measure heart size using noncontrast-enhanced computed tomography: correlation with left ventricular mass","volume":"32","author":"Daniel","year":"2008","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.clnesp.2025.11.010_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijcard.2020.12.029","article-title":"Prognostic importance of left atrial size measured by non-contrast cardiac computed tomography - a DANCAVAS study","volume":"328","author":"Fredgart","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clnesp.2025.11.010_bib18","series-title":"Social. AMdSyD: 2\u00b0 Encuesta Nacional de Nutrici\u00f3n y Salud ENNyS2","year":"2019"},{"issue":"4","key":"10.1016\/j.clnesp.2025.11.010_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.clnesp.2025.11.010_bib20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.clnesp.2025.11.010_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.clnesp.2025.11.010_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41575-021-00472-y","article-title":"Dietary carbohydrates and fats in nonalcoholic fatty liver disease","volume":"18","author":"Yki-Jarvinen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.010_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clnesp.2025.11.010_bib24","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.010_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18030857","article-title":"Gender differences in the relationships among metabolic syndrome and various obesity-related indices with nonalcoholic fatty liver disease in a Taiwanese population","volume":"18","author":"Lin","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.010_bib26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00535-025-02242-y","article-title":"Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis","volume":"60","author":"Tsutsumi","year":"2025","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.010_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70035","article-title":"Sex-specific impact of metabolic dysfunction-associated fatty liver disease on incident cardiovascular diseases and mortality","volume":"8","author":"Abbaszadeh","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"issue":"8","key":"10.1016\/j.clnesp.2025.11.010_bib28","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.tcm.2022.05.006","article-title":"Importance of resting heart rate","volume":"33","author":"Olshansky","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.clnesp.2025.11.010_bib29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.numecd.2017.04.004","article-title":"Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - a systematic review and dose-response meta-analysis of prospective studies","volume":"27","author":"Aune","year":"2017","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.010_bib30","article-title":"Incremental changes in QRS duration as predictor for cardiovascular disease: a 21-year follow-up of a randomly selected general population","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2025.11.010_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1475-2840-12-57","article-title":"Metabolic disturbances and worsening of atherosclerotic lesions in ApoE-\/- mice after cola beverages drinking","volume":"12","author":"Otero-Losada","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnesp.2025.11.010_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112237","article-title":"Effect of low-and non-calorie sweeteners on the gut microbiota: a review of clinical trials and cross-sectional studies","volume":"117","author":"Gauthier","year":"2024","journal-title":"Nutrition"},{"issue":"5","key":"10.1016\/j.clnesp.2025.11.010_bib33","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00394-019-01996-5","article-title":"Non-nutritive sweeteners and their association with the metabolic syndrome and non-alcoholic fatty liver disease: a review of the literature","volume":"58","author":"Green","year":"2019","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnesp.2025.11.010_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1119118","article-title":"Dairy product consumption was associated with a lower likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"10","author":"Dai","year":"2023","journal-title":"Front Nutr"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.010_bib35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/hepr.14020","article-title":"Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U\/L, exercise habits, and metabolic dysfunction-associated steatotic liver disease","volume":"54","author":"Nakano","year":"2024","journal-title":"Hepatol Res"},{"issue":"38","key":"10.1016\/j.clnesp.2025.11.010_bib36","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1093\/eurheartj\/ehaf390","article-title":"First myocardial infarction: risk factors, symptoms, and medical therapy","volume":"46","author":"Nurmohamed","year":"2025","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.clnesp.2025.11.010_bib37","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/echo.13545","article-title":"Diagnosis of fatty liver by computed tomography coronary artery calcium score","volume":"34","author":"Kerut","year":"2017","journal-title":"Echocardiography"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.010_bib38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12072-023-10620-y","article-title":"Breaking new ground: MASLD vs. MAFLD-which holds the key for risk stratification?","volume":"18","author":"Ramirez-Mejia","year":"2024","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.clnesp.2025.11.010_bib39","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.jhep.2024.03.042","article-title":"The MASLD criteria overlook a number of adolescent patients with severe steatosis","volume":"81","author":"Pan","year":"2024","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clnesp.2025.11.010_bib40","doi-asserted-by":"crossref","first-page":"104024","DOI":"10.1016\/j.numecd.2025.104024","article-title":"Comparative association of MAFLD\/MASLD and subtypes with cardiovascular diseases outcomes","volume":"35","author":"Jin","year":"2025","journal-title":"Nutr Metabol Cardiovasc Dis"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725030037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725030037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T18:28:57Z","timestamp":1768760937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725030037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"alternative-id":["S2405457725030037"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.11.010","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gender\u2013specific associations between metabolic dysfunction-associated fatty liver disease with atherosclerosis, inflammation, and eating habits","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}